165 related articles for article (PubMed ID: 12044809)
1. Piceatannol, a Syk-selective tyrosine kinase inhibitor, attenuated antigen challenge of guinea pig airways in vitro.
Seow CJ; Chue SC; Wong WS
Eur J Pharmacol; 2002 May; 443(1-3):189-96. PubMed ID: 12044809
[TBL] [Abstract][Full Text] [Related]
2. Inhibitors of tyrosine kinase signaling cascade attenuated antigen challenge of guinea-pig airways in vitro.
Tsang F; Fred Wong WS
Am J Respir Crit Care Med; 2000 Jul; 162(1):126-33. PubMed ID: 10903231
[TBL] [Abstract][Full Text] [Related]
3. Effects of mitogen-activated protein kinase kinase inhibitor PD 098059 on antigen challenge of guinea-pig airways in vitro.
Tsang F; Koh AH; Ting WL; Wong PT; Wong WS
Br J Pharmacol; 1998 Sep; 125(1):61-8. PubMed ID: 9776345
[TBL] [Abstract][Full Text] [Related]
4. Inhibitor of p42/44 mitogen-activated protein kinase, but not p38 MAPK, attenuated antigen challenge of guinea pig airways in vitro.
Chue SC; Seow CJ; Duan W; Yeo KS; Koh AH; Wong WS
Int Immunopharmacol; 2004 Aug; 4(8):1089-98. PubMed ID: 15222984
[TBL] [Abstract][Full Text] [Related]
5. Effects of tyrosine kinase inhibitors on antigen challenge of guinea pig lung in vitro.
Wong WS; Koh DS; Koh AH; Ting WL; Wong PT
J Pharmacol Exp Ther; 1997 Oct; 283(1):131-7. PubMed ID: 9336317
[TBL] [Abstract][Full Text] [Related]
6. Inhibition of mast cell Fc epsilon R1-mediated signaling and effector function by the Syk-selective inhibitor, piceatannol.
Oliver JM; Burg DL; Wilson BS; McLaughlin JL; Geahlen RL
J Biol Chem; 1994 Nov; 269(47):29697-703. PubMed ID: 7961959
[TBL] [Abstract][Full Text] [Related]
7. Eupatilin blocks mediator release via tyrosine kinase inhibition in activated guinea pig lung mast cells.
Kim JY; Kwon EY; Lee YS; Kim WB; Ro JY
J Toxicol Environ Health A; 2005 Dec; 68(23-24):2063-80. PubMed ID: 16326424
[TBL] [Abstract][Full Text] [Related]
8. Piceatannol is an effective inhibitor of IgE-mediated secretion from human basophils but is neither selective for this receptor nor acts on syk kinase at concentrations where mediator release inhibition occurs.
Miura K; Lavens-Phillips S; MacGlashan DW
Clin Exp Allergy; 2001 Nov; 31(11):1732-9. PubMed ID: 11696049
[TBL] [Abstract][Full Text] [Related]
9. Syk activation initiates downstream signaling events during human polymorphonuclear leukocyte phagocytosis.
Raeder EM; Mansfield PJ; Hinkovska-Galcheva V; Shayman JA; Boxer LA
J Immunol; 1999 Dec; 163(12):6785-93. PubMed ID: 10586078
[TBL] [Abstract][Full Text] [Related]
10. Crystal-induced neutrophil activation. VII. Involvement of Syk in the responses to monosodium urate crystals.
Desaulniers P; Fernandes M; Gilbert C; Bourgoin SG; Naccache PH
J Leukoc Biol; 2001 Oct; 70(4):659-68. PubMed ID: 11590204
[TBL] [Abstract][Full Text] [Related]
11. Inhibition of allergic inflammation in the airways using aerosolized antisense to Syk kinase.
Stenton GR; Ulanova M; Déry RE; Merani S; Kim MK; Gilchrist M; Puttagunta L; Musat-Marcu S; James D; Schreiber AD; Befus AD
J Immunol; 2002 Jul; 169(2):1028-36. PubMed ID: 12097411
[TBL] [Abstract][Full Text] [Related]
12. Effects of inhibitors of the tyrosine kinase signaling cascade on an in vitro model of allergic airways.
Wong WS; Tsang F; Li H; Ma B
Asian Pac J Allergy Immunol; 1999 Sep; 17(3):229-37. PubMed ID: 10697263
[TBL] [Abstract][Full Text] [Related]
13. Pharmacological comparison of LTB(4)-induced NADPH oxidase activation in adherent and non-adherent guinea-pig eosinophils.
Lynch OT; Giembycz MA; Barnes PJ; Lindsay MA
Br J Pharmacol; 2001 Oct; 134(4):797-806. PubMed ID: 11606320
[TBL] [Abstract][Full Text] [Related]
14. Exposure of RBL-2H3 mast cells to Ag(+) induces cell degranulation and mediator release.
Suzuki Y; Yoshimaru T; Yamashita K; Matsui T; Yamaki M; Shimizu K
Biochem Biophys Res Commun; 2001 May; 283(3):707-14. PubMed ID: 11341783
[TBL] [Abstract][Full Text] [Related]
15. Inhibition of spleen tyrosine kinase attenuates allergen-mediated airway constriction.
Moy LY; Jia Y; Caniga M; Lieber G; Gil M; Fernandez X; Sirkowski E; Miller R; Alexander JP; Lee HH; Shin JD; Ellis JM; Chen H; Wilhelm A; Yu H; Vincent S; Chapman RW; Kelly N; Hickey E; Abraham WM; Northrup A; Miller T; Houshyar H; Crackower MA
Am J Respir Cell Mol Biol; 2013 Dec; 49(6):1085-92. PubMed ID: 23889698
[TBL] [Abstract][Full Text] [Related]
16. Transfection of Syk protein tyrosine kinase reconstitutes high affinity IgE receptor-mediated degranulation in a Syk-negative variant of rat basophilic leukemia RBL-2H3 cells.
Zhang J; Berenstein EH; Evans RL; Siraganian RP
J Exp Med; 1996 Jul; 184(1):71-9. PubMed ID: 8691151
[TBL] [Abstract][Full Text] [Related]
17. A novel model of IgE-mediated passive pulmonary anaphylaxis in rats.
Wex E; Thaler E; Blum S; Lamb D
PLoS One; 2014; 9(12):e116166. PubMed ID: 25541997
[TBL] [Abstract][Full Text] [Related]
18. Wortmannin blocks lipid and protein kinase activities associated with PI 3-kinase and inhibits a subset of responses induced by Fc epsilon R1 cross-linking.
Barker SA; Caldwell KK; Hall A; Martinez AM; Pfeiffer JR; Oliver JM; Wilson BS
Mol Biol Cell; 1995 Sep; 6(9):1145-58. PubMed ID: 8534912
[TBL] [Abstract][Full Text] [Related]
19. The use of selective pharmacological inhibitors to delineate signal transduction pathways activated during complement receptor-mediated degranulation in chicken heterophils.
Kogut MH; Lowry VK; Farnell M
Int Immunopharmacol; 2003 May; 3(5):693-706. PubMed ID: 12757738
[TBL] [Abstract][Full Text] [Related]
20. Piceatannol inhibits TNF-induced NF-kappaB activation and NF-kappaB-mediated gene expression through suppression of IkappaBalpha kinase and p65 phosphorylation.
Ashikawa K; Majumdar S; Banerjee S; Bharti AC; Shishodia S; Aggarwal BB
J Immunol; 2002 Dec; 169(11):6490-7. PubMed ID: 12444159
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
